Estrella Immunopharma, Inc. Share Price
ESLAEstrella Immunopharma, Inc. Stock Performance
Open $1.94 | Prev. Close $1.88 | Circuit Range N/A |
Day Range $1.93 - $1.94 | Year Range $0.78 - $3.08 | Volume 200 |
Average Traded $1.94 |
Estrella Immunopharma, Inc. Share Price Chart
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
Estrella Immunopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $1.93 | $1.91 | +10.40% |
07-Apr-26 | $1.57 | $1.73 | +24.46% |
06-Apr-26 | $1.35 | $1.39 | +26.36% |
01-Apr-26 | $1.02 | $1.10 | +5.77% |
31-Mar-26 | $1.04 | $1.04 | -0.48% |
30-Mar-26 | $1.04 | $1.04 | -2.34% |
27-Mar-26 | $1.06 | $1.07 | +3.88% |
FAQs on Estrella Immunopharma, Inc. Share Price
Can I buy Estrella Immunopharma, Inc. shares in India?
What is the share price of Estrella Immunopharma, Inc.?
What is the 5 year returns of Estrella Immunopharma, Inc.?
What are the high & low stock price of Estrella Immunopharma, Inc. today?
What is the 52-week high and low of Estrella Immunopharma, Inc. stock?